Research ArticleBasic Science Investigation
CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer
Cinzia Imberti, Roberto De Gregorio, Joshua A. Korsen, Tran T. Hoang, Samantha Khitrov, Teja Kalidindi, Subhiksha Nandakumar, Jooyoung Park, Samir Zaidi, Naga Vara Kishore Pillarsetty and Jason S. Lewis
Journal of Nuclear Medicine May 2024, jnumed.123.267107; DOI: https://doi.org/10.2967/jnumed.123.267107
Cinzia Imberti
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
Roberto De Gregorio
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
Joshua A. Korsen
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
2Department of Pharmacology, Weill Cornell Medicine, New York, New York;
Tran T. Hoang
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
2Department of Pharmacology, Weill Cornell Medicine, New York, New York;
Samantha Khitrov
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
Teja Kalidindi
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
Subhiksha Nandakumar
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York;
Jooyoung Park
4Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea;
Samir Zaidi
5Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, New York;
6Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York;
Naga Vara Kishore Pillarsetty
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
7Department of Radiology, Weill Cornell Medicine, New York, New York; and
Jason S. Lewis
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
2Department of Pharmacology, Weill Cornell Medicine, New York, New York;
7Department of Radiology, Weill Cornell Medicine, New York, New York; and
8Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer
Cinzia Imberti, Roberto De Gregorio, Joshua A. Korsen, Tran T. Hoang, Samantha Khitrov, Teja Kalidindi, Subhiksha Nandakumar, Jooyoung Park, Samir Zaidi, Naga Vara Kishore Pillarsetty, Jason S. Lewis
Journal of Nuclear Medicine May 2024, jnumed.123.267107; DOI: 10.2967/jnumed.123.267107
CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer
Cinzia Imberti, Roberto De Gregorio, Joshua A. Korsen, Tran T. Hoang, Samantha Khitrov, Teja Kalidindi, Subhiksha Nandakumar, Jooyoung Park, Samir Zaidi, Naga Vara Kishore Pillarsetty, Jason S. Lewis
Journal of Nuclear Medicine May 2024, jnumed.123.267107; DOI: 10.2967/jnumed.123.267107
Jump to section
Related Articles
Cited By...
- No citing articles found.